Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach-Reference-Cited by-同舟云学术

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

Published:2022-02-25 Issue:5 Volume:97 Page:514-518
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Arber Daniel A.¹^ORCID,Hasserjian Robert P.²,Orazi Attilio³,Mathews Vikram⁴^ORCID,Roberts Andrew W.⁵,Schiffer Charles A.⁶,Roug Anne Stidsholt⁷,Cazzola Mario⁸,Döhner Hartmut⁹,Tefferi Ayalew¹⁰^ORCID

Affiliation:

1. Department of Pathology University of Chicago Chicago Illinois USA

2. Department of Pathology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

3. Department of Pathology Texas Tech University Health Sciences Center El Paso Texas USA

4. Department of Hematology Christian Medical College Vellore Tamil Nadu India

5. Department of Clinical Hematology Royal Melbourne Hospital and Peter MacCallum Cancer Centre Melbourne Victoria Australia

6. Department of Oncology, Karmanos Cancer Institute Wayne State University Detroit Michigan USA

7. Department of Clinical Medicine Aarhus University Hospital Aarhus Denmark

8. Department of Molecular Medicine Fondazione IRCCS Policlinico San Matteo and University of Pavia Pavia Italy

9. Department of Internal Medicine University of Ulm Ulm Germany

10. Division of Hematology Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26503

Reference27 articles.

1. UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Comparative Analysis of AML Classification Systems: Evaluating the WHO, ICC, and ELN Frameworks and Their Distinctions;Cancers;2024-08-22

3. Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia;Biomedicines;2024-08-06

4. Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia;American Journal of Hematology;2024-06-06

5. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations;Pathology;2024-06